Abstract : Fampridine improves walking in patients with multiple sclerosis (pwMS). However, little is known about its impact on the quality of life (QoL) of pwMS.
https://hal-univ-fcomte.archives-ouvertes.fr/hal-03630208 Contributor : Eloi MagninConnect in order to contact the contributor Submitted on : Monday, April 4, 2022 - 6:55:56 PM Last modification on : Monday, April 4, 2022 - 6:55:57 PM
Yoshimasa Sagawa, Eloi Magnin, Laura Paillot, Thierry Moulin, Pierre Decavel. Fampridine and quality of life in individuals with multiple sclerosis. SpringerPlus, SpringerOpen, 2016, 5 (1), pp.1070. ⟨10.1186/s40064-016-2776-2⟩. ⟨hal-03630208⟩